Utah Medical Products Inc: (NASD: UTMD)
$48.61
0.17 (0.35%)
Volume 2,776
May 22 04:00 PM ET
Zacks Rank: NA 
| |
Overview Quote
Stock Activity
| Day Low - High | 48.22 - 49.19 |
| 52wk Low - High | 30.00 - 49.85 |
| Previous Close | 48.44 |
| Avg. Volume | 5,915 |
| Industry | MED PRODUCTS |
| Market Cap | 179.86 M |
| Div - Yield | 0.98 - 2.02 |
| Beta | 0.24 |
| PE (Forward) | 0.00 |
| Current Year Est. | 0.00 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
|
Zacks Recommendation
|
No Zacks Recommendation |
Zacks Industry Rank
|
177 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | NA |
| PEG Ratio | NA |
| Current Year Est. | NA |
| Current Quarter Estimate | NA |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | 07-25-2013 |
| EPS Last Year | 2.72 |
| Expected Earnings Growth | NA |
Company Description
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvements over existing clinical techniques.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (ND) |
Next Qtr (ND) |
Current Year (ND) |
Next Year (ND) |
|
|---|---|---|---|---|
| Average Estimate | NA | NA | NA | NA |
| Number of Estimates | NA | NA | NA | NA |
| Low Estimate | NA | NA | NA | NA |
| High Estimate | NA | NA | NA | NA |
| Year Ago EPS | NA | NA | NA | NA |
| EPS Growth | NA | NA | NA | NA |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| ATRICURE INC | ATRC | 8.99 | |
|
| CONCEPTUS INC | CPTS | 30.98 | |
|
| INVIVO THERAPT | NVIV | 2.90 | |
|
| TRANS1 INC | TSON | 1.59 | |
|
| ABAXIS INC | ABAX | 44.22 | |
|
| ADVAXIS INC | ADXS | 0.05 | |
|
| BAXTER INTL | BAX | 73.04 | |
|
| BIO-RAD LABS -A | BIO | 116.12 | |
|
| BIOLIFE SOL INC | BLFS | 0.38 | |
|
| BOSTON SCIENTIF | BSX | 9.23 | |
|
Sector:Medical>> Industry:MED PRODUCTS
COMPARE TICKER vs. Its Peers
Zacks Commentary
Financials
| EPS TTM | 2.72 |
| Sales | 42 |
| Net Income | 10 |
| Price/Earnings | 17.81 |
| Price/Book | 3.55 |
| Price/Cash Flow | 13.29 |
| Price/Sales | 4.42 |
News
Alere is Among the Companies in the Health Care Supplies Industry With the Highest Forward Earnings Yield (ALR, XRAY, UTMD) - Financial News Network Online - News Corner
May 21, 2013
Utah Medical Products Q1 net income decreases - Datamonitor
May 8, 2013
Utah Medical Products, Inc. Announces Quarterly Dividend - Globenewswire
May 7, 2013
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2013 - Globenewswire
Apr 25, 2013
Meridian Bioscience is Among the Companies in the Health Care Supplies Industry With the Highest Dividend Yield (VIVO, SPAN, UTMD) - Financial News Network Online - News Corner
Apr 23, 2013
Utah Medical Products IncCorporate Event Announcement Notice - Wall Street Horizon
Apr 11, 2013
Utah Medical Products IncCorporate Event Announcement Notice - Wall Street Horizon
Apr 10, 2013
Utah Medical Products IncCorporate Event Announcement Notice - Wall Street Horizon
Apr 9, 2013
Broker Recommendations
| Current ABR | 1.00 |
| ABR (Last Week) | 1.00 |
| # of recs in ABR | 1 |
| Average Target Price | NA |
| Industry Rank by ABR | 177 out of 265 |
| Rank in Industry | NA |
